A double-blind, randomized, prospective evaluation of the efficacy and safety of risperidone versus haloperidol in the treatment of schizoaffective disorder.

P G Janicak; P E Keck; J M Davis; J W Kasckow; K Tugrul; S M Dowd; J Strong; R P Sharma; S M Strakowski

doi:10.1097/00004714-200108000-00002

A double-blind, randomized, prospective evaluation of the efficacy and safety of risperidone versus haloperidol in the treatment of schizoaffective disorder.

Identifier:nobleid.org/w1/20260515/38DF16E2

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/38DF16E2.svg?ark=w1%2F20260515%2F38DF16E2)](https://nobleid.org/work/w1/20260515/38DF16E2)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

A double-blind, randomized, prospective evaluation of the efficacy and safety of risperidone versus haloperidol in the treatment of schizoaffective disorder.

Identifier:nobleid.org/w1/20260515/38DF16E2

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/38DF16E2.svg?ark=w1%2F20260515%2F38DF16E2)](https://nobleid.org/work/w1/20260515/38DF16E2)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work